Genepeutic Bio Gets Supports from Thailand Board of Investment

  • News & Events

The Thailand Board of Investment (BOI) has approved business promotions for new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around USD78 million) in investment, which include Genepeutic Bio, a biotech startup for advance therapeutic medical products (ATMPs) manufacturing.

Continue reading : https://www.boi.go.th/index.php?page=press_releases_detail&topic_id=127717

  • Share this article
  • News & Events

CEO Club 2021: Biotechnology ต่อยอดธุรกิจใน New S-Curve

https://www.setlink.set.or.th/main?type=activity&id=73307
Read More
  • News & Events

THEIR OWN MEDICINE : Our Story from The Economist

Biotech entrepreneurs are building on Thailand’s robust industry ecosystem to make advanced health care more accessible.
Read More
  • News & Events

Genepeutic Bio and NSTDA Sign an Investment Deal Agreement

This partnership strengthens the local scientific innovation start-up company and supports Thailand into a medical hub for the therapeutic applications in cell and gene immunotherapies for cancers and other potential diseases.
Read More

GENEPEUTIC BIO CO.,LTD

Genepeutic Bio was founded in 2020 to deliver the next wave of personalized cell and gene therapy for patients in Asia, initiating with Chimeric antigen receptor (CAR) T-cells.

NAVIGATION

HOME

SERVICES AND SOLUTIONS

OUR SCIENCES

PRODUCT

ABOUT

NEWS & EVENTS

CONTACT

GNPT - FACT SHEET ( PDF )

CONTACT US